Search
Presentation: Brian Malkin, Arent Fox LLP
… Attorney Ethics in Representing Clients in the Medical Marijuana Industry” – focus on NYSBA Ethics Opinion, Cole … • May 2018 Albany - Legislative Developments Medical Marijuana and Hemp • August 2018 - Medical Marijuana Perspectives (medical and growers) and Adult Use • …
Presentation: Is There a Risk of Blindness With CBD? 5-31-19
… A. VALENTI CEO/PRESIDENT IMMAD, LLC IMPAIRMENT MEASUREMENT MARIJUANA AND DRIVING OPTOMETRIST RESIDENCY TRAINED IN VISION … Pressure In Eye With CBD While we often hear of marijuana being able to lower the pressure in the eye; this is only with THC, the psychoactive cannabinoid in marijuana. We never hear about CBD and its increasing of …
FDA FOIA Log - December 2023
… of CTP officials regarding the schedule classification of marijuana and the recommendation to move marijuana from a Schedule I drug to a Schedule III drug. 2. … (cdc.gov) regarding the schedule classification of marijuana and the recommendation to move marijuana from a …
Presentation: Smart Regulation of Products Containing Cannabis or Cannabis-Derived Compounds, Specifically Cannabidiol (CBD)
… mal seizure in eight months to make the transition to marijuana. I smoked nightly – it helped me sleep and provided … and dejection. I felt like a new person. Medical marijuana became part of my routine and it changed my life. Since using marijuana, I no longer worry about seizing in a public place …
Presentation: Consumer Behavior and Assessing Effects of Cannabis Products 5-31-19
… delivery types Presenter Presentation Notes Other form of Marijuana Weighted % Cannabis transdermal patches, lotions, … delivery types Presenter Presentation Notes Other form of Marijuana Weighted % Cannabis transdermal patches, lotions, … each of the following reasons? [IF CO_USE = 0, PIPE IN “marijuana” IF CO_USE = 1, PIPE IN “marijuana and …
Joseph N. Cappella
… Y. Cappella, J.N., & Fishbein, M. (2009). The Effect of Marijuana Scenes in Anti- marijuana Public Service Announcements on Adolescents' … Ahern, R.K.. (2006). Targeting Norm-Related Beliefs about Marijuana Use in an Adolescent Population. Health …
Full Final Agenda for the FDA Public Hearing The FDA's Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, May 31, 2019
… Consumers • Susan Cromer LilyHemp • Sally Schindel Marijuana Victims Alliance 2 Health Professionals • Corey … Healthcare Products Association • Stuart Titus Medical Marijuana • Julian Wright Science & Recreation Other • … concludes) Consumer • Pamela McColl Smart Approaches to Marijuana Canada 10:37 AM – 12:30 PM Formal Presentations …
Opioid Misuse and Opioid Use Disorders in Adolescents
… Casey BJ, et al., Development Reviews. 2008; 28: 62-77. marijuana Image retrieved on February 17, 2015, from … 0 5 10 15 20 13 15 17 19 21+ 17 16 11 8 4 Alcohol Marijuana % w ith M ar iju an a Di so rd er Age at First Use … Alc/MJ/tobacco use Gateway to Opioid Misuse Lifetime Marijuana use AOR: 2.44 (95% CI 2.22-2.67) Lifetime Cigarette …
2019-Q4-TPPR.csv
… ineffective / Fever / Flu / Generalized muscle aches / Marijuana abuse / Night sweats No 0 No information provided … disorder / Attention deficit/hyperactivity disorder / Marijuana use No 0 No information provided 2076600 11/6/2019 … Depression / Feeling bad / Fever / Heart rate increased / Marijuana use / Migraine / Nausea / Vomiting No 0 No …
2019-TPPR.csv
… ineffective / Fever / Flu / Generalized muscle aches / Marijuana abuse / Night sweats No 0 No information provided … disorder / Attention deficit/hyperactivity disorder / Marijuana use No 0 No information provided 2076600 11/6/2019 … Depression / Feeling bad / Fever / Heart rate increased / Marijuana use / Migraine / Nausea / Vomiting No 0 No …
SRO Added - June 2020
… USA DRVD OTHER OTC Market 086425788 Marijuana Company of America, Inc. USA MCOA OTHER OTC Market …
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
… regulations. 8 The CSA uses the spelling marihuana; marijuana is a common alternative. 9 See 21 U.S.C. 802(16). … NIDA’s DSP, see https://www.drugabuse.gov/drugs-abuse/marijuana/nidas-role-in- providing-marijuana-research. 22 See 21 CFR 1318 for information on …
Presentation: Recent Research Findings and the Legalization of Hemp
… 1-14. 4. Cox EJ, Maharao N, Patilea-Vrana G, et al. A marijuana-drug interaction primer: Precipitants, pharmacology …
Presentation: Barriers to CBD/Cannabis Clinical Trials in US 5-31-19
… under Controlled Substances Act (CSA) to grow/manufacture marijuana to supply legitimate researchers in US … ell/2017/11/07/dea-wants-feds-to-grow-almost-1000-pounds-of-marijuana-next-year/2/#34ecc21a44ae FDA REQUIRES PHASE 3 … IS SEEKING TO MARKET LATER NIDA authorized to provide marijuana for research but not for sale by prescription as …
CannibisQualityGUI_pdf
… regulations. 12 The CSA uses the spelling marihuana; marijuana is a common alternative. 13 See 21 U.S.C. 802. … NIDA’s DSP, see https://www.drugabuse.gov/drugs-abuse/marijuana/nidas-role-in- providing-marijuana-research. 19 DEA is currently in the process of …
Scientific Memorandum: Cannabidiol (CBD) (01/19/2022)
… PMID: 34626752. Neradugomma NK, Drafton K, Mor GG, Mao Q. Marijuana-derived cannabinoids inhibit uterine endometrial …
The Modern Science of Addiction
… Alcohol Use – ever ~ 260 million Alcoholism ~ 16.5 million Marijuana Use – ever ~ 104 million Marijuana Daily Use ~ 5.7 million Cocaine Use – ever ~ 45.6 … After Self Exposure (meta-analyses) Alcoholism, Cocaine, Marijuana Addictions ~ 1 in 8 to 1 in 15 Heroin Addiction ~ 1 …
FDA Role in Regulation of Cannabis Products Presentation
… of THC • Removed hemp from the definition of marijuana in the Controlled Substances Act (CSA) • Marijuana is still regulated by DEA under Schedule 1 of the … Designation, Breakthrough Therapy Designation • “FDA and Marijuana” web page includes links to Q&A page, guidance on …
Presentation: Heather Despres, Americans for Safe Access 5-31-19
… (ASA) is to ensure safe and legal access to cannabis (marijuana) for therapeutic use and research.” Patient Focused … (ASA) is to ensure safe and legal access to cannabis (marijuana) for therapeutic use and research.” Slide Number 3 …
FDA Role in Regulation of Cannabis Products NJACCHO meeting 16SEP21 FINAL
… a plan to USDA • Removed hemp from the definition of marijuana in the Controlled Substances Act (CSA) – Hemp: … on a dry weight basis) concentrations of delta-9 THC • Marijuana is still regulated by DEA under Schedule 1 of the … substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. 5 things you should …
Safety of CBD in Humans – A Literature Review (As of December 12, 2019)
… basis) concentrations of THC) from the definition of marijuana under the Controlled Substances Act (CSA). However, … • Review articles2 • Clinical trials that used cannabis, marijuana, THC, 3 or CBD-THC combination • Surveys on human … of “CBD” products • Clinical trials that used cannabis, marijuana, THC, or CBD-THC combination • Clinical trials that …
FDA Oral History Interview, Stuart L. Nightingale
… of an Unproven Remedy, July-August 1984 D Publication: Marijuana and Heroin by Prescription, Nightingale and Perry, … with addictive drugs as opposed to things like LSD or marijuana or . . . SLN: It was all drugs of abuse, both … on state programs to legalize the provision of medical marijuana, marijuana to be used for treatment purposes in …
Stuart Nightingale Oral History
… of an Unproven Remedy, July-August 1984* D Publication: Marijuana and Heroin by Prescription, Nightingale and Perry, … with addictive drugs as opposed to things like LSD or marijuana or . . . SLN: It was all drugs of abuse, both … on state programs to legalize the provision of medical marijuana, marijuana to be used for treatment purposes in …
Stuart Nightingale Oral History
… of an Unproven Remedy, July-August 1984* D Publication: Marijuana and Heroin by Prescription, Nightingale and Perry, … with addictive drugs as opposed to things like LSD or marijuana or . . . SLN: It was all drugs of abuse, both … on state programs to legalize the provision of medical marijuana, marijuana to be used for treatment purposes in …
2023 Annual Report Office of Communications Center for Drug and Evaluation Research
… CDER. Our 2023 reports described 81 unique substances. ■ Marijuana: Based on an administration directive to explore whether marijuana should remain listed as Schedule I under the … a detailed qualitative analysis of conversations about marijuana online and on social media. The findings from these …